Accelerate Research & Clinical Development

Delivering the global R&D and clinical trial services that are driving cell and gene therapy innovations

The united power of trials, labs, and data combined with unparalleled experience with cell and gene therapies is accelerating greater insight and faster cell and gene therapy development. By integrating these critical services within a single global organization, Precision amplifies proven scientific approaches, streamlines complex processes and minimizes risk.

50+ research and clinical development projects supported in the last two years

Child wearing mask receiving shot in arm

Cell and Gene Therapy Clinical Trial Development

New treatment modalities—such as cell and gene therapies—require novel approaches to demonstrating safety and efficacy. From pre-clinical through registration studies, our experts are leaders in the advancement of cell and gene therapy development, leveraging the research interests of the sites to build clinical enthusiasm, supporting the logistical complexities of these trials, and addressing complex safety issues.

Cell and Gene Therapy Study Experience

Our teams bring broad-reaching experience in both cell and gene therapies, spanning therapeutic areas including oncology, CNS, autoimmune disease, cardiovascular disease, and hemophilia. With our experience in rare diseases, solid and liquid tumors, our teams meet logistical and regulatory challenges with bold solutions that accelerate your cell and gene therapy development pathway.

Cell Therapy –Autologous and Allogeneic

CAR-T cells
Stem cells
Tumor-infiltrating lymphocytes
TCR Therapy
Cell Therapy – Other

Gene Therapy

CRISPR
Multiple AAV serotypes
Lentivirus
Exosomes

Clinical Trial Design and Execution

Cell and gene therapy clinical trials require distinct skill sets. Our multidisciplinary teams have these skills, with global cell and gene therapy expertise across clinical trial operations, regulatory, pharmacovigilance, and medical monitoring. These experts anticipate obstacles and provide strategic guidance—ensuring site-to-site consistency in crucial processes from raw material collection to bedside therapeutic administration.

Clinical development strategy and planning
- Study design and protocol development
- Manufacturing logistics
- Toxicity Management Guidelines
Cell and gene therapy experience navigating CBER, CDER, and ex-US Regulators, as well as site-level IBC requirements for cell and gene therapy
Experienced Investigators with documented experience in cell and gene therapy
- Investigational Product Receipt and Processing Plan
- Logistical oversight of supply chain management
- Labelling requirements
Robust data-driven monitoring strategy
Rapid AE identification and management
- Ongoing patient safety and data trend analysis
Data Safety Monitoring Boards
Data collection strategy
- eCRF development
- Data visualizations
- Scientific and medical remote data review
Biometrics/biostatistics and oversight
CDISC programming and documentation

Global Sample Processing and Logistics

Logistics for both allogeneic and autologous cell therapy, as well as gene therapy studies require a high level of coordination, organization and oversight. We are meticulous, precisely orchestrating sample collection based on protocol requirements to mitigate risk and ensure trial success.

Customized kit manufacturing
Site support and lab manuals
Real-time sample processing (assays and PBMCs)
Virtual Sample Inventory Management
Global biobanking (tissue and cells)
Quality standards and certifications (CAP, ISO, GxP)
Transport management and 24/7 tracking and reporting

Gloved hand pointing at cell and gene therapy development

Specialty Lab Services for Gene and Cell Therapy Clinical Trials Research

Cell and gene therapy clinical trials research requires specialized expertise to support successful translation from the bench to the clinic. We deliver, with a broad array of both established and Precision-engineered platforms targeted specifically to the needs of cell or gene therapy development, and thought leaders who are helping shape the therapeutic and regulatory landscape.

Cell Therapy Lab Capabilities

Laboratory assays for evaluating the efficacy and safety of cell therapies—which are essentially living drugs—may require innovative approaches. We support cell therapy development, from providing insight into cell biology and pharmacodynamics to generating quantitative data that can be used to optimize the profile and manufacturing of these complex therapeutics.

Molecular characterization of CAR T-cells using the nCounter® CAR-T Characterization Panel
Cell expansion, distribution and persistence assays using ddPCR or flow cytometry
Cytokine, chemokine, and pro-inflammatory assays
Sequencing for aberrant CRISPR events
Measurement of minimal residual disease using flow cytometry or NGS
Liquid biopsy using ApoStream^TM for CTC and rare cell capture and enrichment
IHC and multiplex IF for immunophenotyping and tumor profiling
Central laboratory testing services for global clinical trials
Epigenetic markers for immune cell lineages

Gene Therapy Lab Capabilities

Gene therapy holds great promise, but this field of research is still in its nascent stages and the optimal methods for unlocking its full clinical potential are still being defined. We support gene therapy development, from exploratory assays for preclinical development to companion diagnostics.

NAb and TAb assays (exploratory to CLIA, CE Mark or CDx)
Immunogenicity testing e.g. ELISpot and Fluorospot
Viral capsid and transgene expression assays
Distribution and persistence assays
Central laboratory testing services for global clinical trials

Companion Diagnostic Services for Cell and Gene Therapies

The success of cell and gene therapies ultimately relies on accurate identification of appropriate candidates for treatment. These precision medicine products often require a Companion Diagnostic (CDx)—and that requires specialized clinical development, biomarker assays, regulatory strategy and commercialization capabilities.

CDx Development

To optimize assay efficacy, we dive deep to understand and address critical pivot points for the proposed CDx, ranging from access optimization to kit compatibility.

TAb and NAb companion diagnostic development
Cell-based, ELISpot, and immunoassay capabilities
Complete analytical studies under full design control
Cell bank development and maintenance
Extensive experience with multiple AAV serotypes
Regulatory strategies for LDTs, IVDs, and CDx
QMS development
FDA pre-submissions
IDE and SRD submissions
510(k), de novo, and PMA submissions
Access, reimbursement, and channel analysis and strategy

Woman with headset reviewing cell and gene therapy logistics

Biomarker and Translational Intelligence

Biomarkers play a critical role in cell and gene therapy programs, identifying risk factors for adverse events and measuring the durability of therapeutic mechanisms. Because of the complexity involved with specialty labs running complex assays globally, we’ve developed a proprietary platform to provide timely visibility into sample availability and quality, data availability and quality, and critical on-study measurements.

Centralizing PK, Clinical, and Exploratory Data

Systems and processes used to track samples and monitor patient status are dispersed across CROs, labs, and sponsors. Precision for Medicine’s QuartzBio® team, has developed proprietary technology-enabled capabilities, to centralize and harmonize this non-standard and siloed data from across the ecosystem.

Integrated visibility across sites, central, and third party special labs
Site-level sample QC metrics and availability
Results-data availability across multiple assay modalities
Assay- and batch-specific data quality on-study